Suk-Woo Ha
Directeur Général chez Bode AG
Profil
Suk-Woo Ha is currently the Managing Director at Vlesia AG, Bode AG, and Director at Qvanteq AG.
Previously, he worked as the Head-Sales & Marketing at IVF HARTMANN AG from 2011 to 2014.
He also served as the Head-Research & Development at Schneider (Europe) GmbH in 1998, Jomed AG from 1999 to 2002, and was a Member-Management Board at FASMED.
Dr. Ha holds a doctorate degree from the Swiss Federal Institute of Technology and an MBA from St. Gallen University of Applied Sciences.
Postes actifs de Suk-Woo Ha
| Sociétés | Poste | Début |
|---|---|---|
Bode AG
 Bode AG Household/Personal CareConsumer Non-Durables Part of SCHWENK Zement GmbH & Co. KG, Bode AG is a Swiss company that manufactures hygiene and disinfection products. The company is based in Münchenstein, Switzerland. The CEO of the company is Suk-Woo Ha. Bode was acquired by IVF HARTMANN AG from SCHWENK Zement GmbH & Co. KG on September 03, 2009. | Directeur Général | 11/04/2011 |
Vlesia AG
 Vlesia AG Pharmaceuticals: MajorHealth Technology Part of SCHWENK Zement GmbH & Co. KG, Vlesia AG is a Swiss company that provides incontinence treatment products. The company is based in Goldach, Switzerland. The CEO of the company is Suk-Woo Ha. Vlesia was acquired by IVF HARTMANN AG from DSG -TEK Ltd on October 01, 2000 for $6.36 million. | Directeur Général | 11/04/2011 |
Qvanteq AG
 Qvanteq AG BiotechnologyHealth Technology Qvanteq AG develops novel bioactive stents to address and overcome the clinical adverse. Its products include technology, intracranial stents, Qstent Periphry, and Qstent Coronary. The company was founded in 2009 and is headquartered in Zurich, Switzerland. | Directeur/Membre du Conseil | - |
Anciens postes connus de Suk-Woo Ha
| Sociétés | Poste | Fin |
|---|---|---|
| Jomed AG | Directeur Technique/Scientifique/R&D | 01/01/2002 |
Schneider (Europe) GmbH
 Schneider (Europe) GmbH Medical SpecialtiesHealth Technology Part of Boston Scientific Corp., Schneider (Europe) GmbH is a Swiss company that makes stents used to prop open arteries and other devices for angioplasty. The company is based in Bulach, Switzerland. Schneider (Europe was acquired by Boston Scientific Corp. from Pfizer Inc. on September 10, 1998 for $2,100 million. | Directeur Technique/Scientifique/R&D | 01/01/1998 |
FASMED
 FASMED Miscellaneous Commercial ServicesCommercial Services FASMED operates as a membership organization for medical device technologies. The private company is based in Muri, Switzerland. | Corporate Officer/Principal | - |
IVF HARTMANN AG
 IVF HARTMANN AG Household/Personal CareConsumer Non-Durables IVF HARTMANN AG engages in the development and production of medical, pharmaceutical, and hygiene products. It offers dental products, elastic bandages, wound treatment solutions, and personal healthcare products. The company was founded in 1870 and is headquartered in Neuhausen, Switzerland. | Sales & Marketing | - |
Formation de Suk-Woo Ha
| Swiss Federal Institute of Technology | Doctorate Degree |
| St. Gallen University of Applied Sciences | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
IVF HARTMANN AG
IVF HARTMANN AG Household/Personal CareConsumer Non-Durables IVF HARTMANN AG engages in the development and production of medical, pharmaceutical, and hygiene products. It offers dental products, elastic bandages, wound treatment solutions, and personal healthcare products. The company was founded in 1870 and is headquartered in Neuhausen, Switzerland. | Consumer Non-Durables |
Schneider (Europe) GmbH
Schneider (Europe) GmbH Medical SpecialtiesHealth Technology Part of Boston Scientific Corp., Schneider (Europe) GmbH is a Swiss company that makes stents used to prop open arteries and other devices for angioplasty. The company is based in Bulach, Switzerland. Schneider (Europe was acquired by Boston Scientific Corp. from Pfizer Inc. on September 10, 1998 for $2,100 million. | Health Technology |
Vlesia AG
Vlesia AG Pharmaceuticals: MajorHealth Technology Part of SCHWENK Zement GmbH & Co. KG, Vlesia AG is a Swiss company that provides incontinence treatment products. The company is based in Goldach, Switzerland. The CEO of the company is Suk-Woo Ha. Vlesia was acquired by IVF HARTMANN AG from DSG -TEK Ltd on October 01, 2000 for $6.36 million. | Health Technology |
Bode AG
Bode AG Household/Personal CareConsumer Non-Durables Part of SCHWENK Zement GmbH & Co. KG, Bode AG is a Swiss company that manufactures hygiene and disinfection products. The company is based in Münchenstein, Switzerland. The CEO of the company is Suk-Woo Ha. Bode was acquired by IVF HARTMANN AG from SCHWENK Zement GmbH & Co. KG on September 03, 2009. | Consumer Non-Durables |
| Jomed AG | |
FASMED
FASMED Miscellaneous Commercial ServicesCommercial Services FASMED operates as a membership organization for medical device technologies. The private company is based in Muri, Switzerland. | Commercial Services |
Qvanteq AG
Qvanteq AG BiotechnologyHealth Technology Qvanteq AG develops novel bioactive stents to address and overcome the clinical adverse. Its products include technology, intracranial stents, Qstent Periphry, and Qstent Coronary. The company was founded in 2009 and is headquartered in Zurich, Switzerland. | Health Technology |